Assembly Biosciences Statistics
Total Valuation
ASMB has a market cap or net worth of $489.81 million. The enterprise value is $265.70 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASMB has 15.89 million shares outstanding. The number of shares has increased by 108.28% in one year.
| Current Share Class | 15.89M |
| Shares Outstanding | 15.89M |
| Shares Change (YoY) | +108.28% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 3.89% |
| Owned by Institutions (%) | 34.14% |
| Float | 7.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.89 |
| Forward PS | n/a |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.65, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.65 |
| Quick Ratio | 6.49 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -5.66% and return on invested capital (ROIC) is -7.32%.
| Return on Equity (ROE) | -5.66% |
| Return on Assets (ROA) | -5.06% |
| Return on Invested Capital (ROIC) | -7.32% |
| Return on Capital Employed (ROCE) | -6.76% |
| Weighted Average Cost of Capital (WACC) | 10.20% |
| Revenue Per Employee | $973,932 |
| Profits Per Employee | -$87,438 |
| Employee Count | 73 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +151.80% in the last 52 weeks. The beta is 1.09, so ASMB's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +151.80% |
| 50-Day Moving Average | 28.65 |
| 200-Day Moving Average | 28.54 |
| Relative Strength Index (RSI) | 59.60 |
| Average Volume (20 Days) | 137,323 |
Short Selling Information
The latest short interest is 1.56 million, so 9.80% of the outstanding shares have been sold short.
| Short Interest | 1.56M |
| Short Previous Month | 1.53M |
| Short % of Shares Out | 9.80% |
| Short % of Float | 20.71% |
| Short Ratio (days to cover) | 15.91 |
Income Statement
In the last 12 months, ASMB had revenue of $71.10 million and -$6.38 million in losses. Loss per share was -$0.48.
| Revenue | 71.10M |
| Gross Profit | 6.28M |
| Operating Income | -13.55M |
| Pretax Income | -6.38M |
| Net Income | -6.38M |
| EBITDA | -13.42M |
| EBIT | -13.55M |
| Loss Per Share | -$0.48 |
Full Income StatementBalance Sheet
The company has $226.60 million in cash and $2.49 million in debt, with a net cash position of $224.11 million or $14.10 per share.
| Cash & Cash Equivalents | 226.60M |
| Total Debt | 2.49M |
| Net Cash | 224.11M |
| Net Cash Per Share | $14.10 |
| Equity (Book Value) | 198.61M |
| Book Value Per Share | 12.50 |
| Working Capital | 197.62M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 128,250 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 8.84%, with operating and profit margins of -19.05% and -8.98%.
| Gross Margin | 8.84% |
| Operating Margin | -19.05% |
| Pretax Margin | -8.98% |
| Profit Margin | -8.98% |
| EBITDA Margin | -18.87% |
| EBIT Margin | -19.05% |
| FCF Margin | n/a |
Dividends & Yields
ASMB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -108.28% |
| Shareholder Yield | -108.28% |
| Earnings Yield | -1.30% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ASMB is $44.20, which is 43.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.20 |
| Price Target Difference | 43.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 19.19% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 12, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 12, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
